Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study.

Medical decision making : an international journal of the Society for Medical Decision Making - 1 Jan 2000

Rogowski Wolf H

Abstract excerpt

OBJECTIVE: Genetic tests for hereditary hemochromatosis (HH) are currently included in the German ambulatory care reimbursement scheme but only for symptomatic individuals and the offspring of HH patients. This study synthesizes the most current evidence to examine whether screening in the broader population is cost-effective and to identify the best choice of initial and follow-up screening tests. METHODS: A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Decision Support Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genotype

Share to Germany

Share to Hemochromatosis

Share to Phenotype

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 19182214
DOI: 10.1177/0272989X08327112

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study.PMID 19182214Read ↗

Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation.Semantic proximity Read ↗

Genetic screening by DNA technology: a systematic review of health economic evidence.Semantic proximity Read ↗

Benefit of population-based screening for phenotypic hemochromatosis in young men.Semantic proximity Read ↗

A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations.Semantic proximity Read ↗

Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness AnalysisSemantic proximity Read ↗

Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.Semantic proximity Read ↗

Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.Semantic proximity Read ↗

Cost savings through molecular diagnosis for hereditary hemorrhagic telangiectasia.Semantic proximity Read ↗

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income CountrySemantic proximity Read ↗

[Should we support large-scale screening for genetic haemochromatosis in France?].Semantic proximity Read ↗

Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.Semantic proximity Read ↗

Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.